Eligibility Dipeptidyl-Peptidase 4 Inhibitors NCT02330406

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with type 2 diabetes with coronary heart diseases who treated with diet, exercise or antidiabetic medications
Descripción

Diabetes Mellitus, Non-Insulin-Dependent | Coronary heart disease | Diet therapy | Treated with Exercise | Treated with Antidiabetics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0010068
UMLS CUI [3]
C0012159
UMLS CUI [4,1]
C0332293
UMLS CUI [4,2]
C0015259
UMLS CUI [5,1]
C0332293
UMLS CUI [5,2]
C0935929
patients who were treated with statins for 8 weeks or longer
Descripción

Treated with Hydroxymethylglutaryl-CoA Reductase Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332293
UMLS CUI [1,2]
C0360714
patients with low-density lipoprotein cholesterol equal to or greater than 100 mg/dl in the at least two of three measurements after the administration of statins
Descripción

Low density lipoprotein cholesterol measurement Post Administration Hydroxymethylglutaryl-CoA Reductase Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0202117
UMLS CUI [1,2]
C0687676
UMLS CUI [1,3]
C1533734
UMLS CUI [1,4]
C0360714
patients with glycerated hemoglobin (hba1c, ngsp) equal to or greater than 6.0 % (7.0
Descripción

hemoglobin, glycerated | Glycosylated hemoglobin A

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0062477
UMLS CUI [2]
C0019018
% if patients were not treated with dipeptidyl-peptidase 4 inhibitors) and lesser than 10.5 %
Descripción

Treated with Dipeptidyl-Peptidase IV Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332293
UMLS CUI [1,2]
C1827106
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with type 1 diabetes
Descripción

Diabetes Mellitus, Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
patients with triglyceride equal to or greater than 400 mg/dl in the previous fasting measuments
Descripción

Triglycerides measurement Fasting

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0202236
UMLS CUI [1,2]
C0015663
patients who were received insulin therapy or considered to need insulin therapy
Descripción

Insulin therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0557978
patients with pregnancy, possible pregnancy, or on breast-feeding
Descripción

Pregnancy | Possible Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0332149
UMLS CUI [2,2]
C0032961
UMLS CUI [3]
C0006147
patients with severe infections, perioperative status, or severe trauma
Descripción

Infection Severe | Status perioperative | Trauma Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3714514
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0449438
UMLS CUI [2,2]
C1518988
UMLS CUI [3,1]
C3714660
UMLS CUI [3,2]
C0205082
patients who were received glucagon-like peptide-1receptor agonists, rapid insulin secretagogue, or sodium glucose cotransporter 2 inhibitor
Descripción

Glucagon-Like Peptide-1 Receptor agonists | Insulin, Rapid-Acting | Sodium-Glucose Cotransporter 2 Inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0378073
UMLS CUI [1,2]
C0243192
UMLS CUI [2]
C0356365
UMLS CUI [3]
C3542461
patients whom physician in charge considered inappropriate for the study
Descripción

Patient Inappropriate Clinical Trial

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C0008976

Similar models

Eligibility Dipeptidyl-Peptidase 4 Inhibitors NCT02330406

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Coronary heart disease | Diet therapy | Treated with Exercise | Treated with Antidiabetics
Item
patients with type 2 diabetes with coronary heart diseases who treated with diet, exercise or antidiabetic medications
boolean
C0011860 (UMLS CUI [1])
C0010068 (UMLS CUI [2])
C0012159 (UMLS CUI [3])
C0332293 (UMLS CUI [4,1])
C0015259 (UMLS CUI [4,2])
C0332293 (UMLS CUI [5,1])
C0935929 (UMLS CUI [5,2])
Treated with Hydroxymethylglutaryl-CoA Reductase Inhibitors
Item
patients who were treated with statins for 8 weeks or longer
boolean
C0332293 (UMLS CUI [1,1])
C0360714 (UMLS CUI [1,2])
Low density lipoprotein cholesterol measurement Post Administration Hydroxymethylglutaryl-CoA Reductase Inhibitors
Item
patients with low-density lipoprotein cholesterol equal to or greater than 100 mg/dl in the at least two of three measurements after the administration of statins
boolean
C0202117 (UMLS CUI [1,1])
C0687676 (UMLS CUI [1,2])
C1533734 (UMLS CUI [1,3])
C0360714 (UMLS CUI [1,4])
hemoglobin, glycerated | Glycosylated hemoglobin A
Item
patients with glycerated hemoglobin (hba1c, ngsp) equal to or greater than 6.0 % (7.0
boolean
C0062477 (UMLS CUI [1])
C0019018 (UMLS CUI [2])
Treated with Dipeptidyl-Peptidase IV Inhibitors
Item
% if patients were not treated with dipeptidyl-peptidase 4 inhibitors) and lesser than 10.5 %
boolean
C0332293 (UMLS CUI [1,1])
C1827106 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
patients with type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Triglycerides measurement Fasting
Item
patients with triglyceride equal to or greater than 400 mg/dl in the previous fasting measuments
boolean
C0202236 (UMLS CUI [1,1])
C0015663 (UMLS CUI [1,2])
Insulin therapy
Item
patients who were received insulin therapy or considered to need insulin therapy
boolean
C0557978 (UMLS CUI [1])
Pregnancy | Possible Pregnancy | Breast Feeding
Item
patients with pregnancy, possible pregnancy, or on breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0332149 (UMLS CUI [2,1])
C0032961 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3])
Infection Severe | Status perioperative | Trauma Severe
Item
patients with severe infections, perioperative status, or severe trauma
boolean
C3714514 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0449438 (UMLS CUI [2,1])
C1518988 (UMLS CUI [2,2])
C3714660 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Glucagon-Like Peptide-1 Receptor agonists | Insulin, Rapid-Acting | Sodium-Glucose Cotransporter 2 Inhibitor
Item
patients who were received glucagon-like peptide-1receptor agonists, rapid insulin secretagogue, or sodium glucose cotransporter 2 inhibitor
boolean
C0378073 (UMLS CUI [1,1])
C0243192 (UMLS CUI [1,2])
C0356365 (UMLS CUI [2])
C3542461 (UMLS CUI [3])
Patient Inappropriate Clinical Trial
Item
patients whom physician in charge considered inappropriate for the study
boolean
C0030705 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])